AngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference
September 06, 2016 08:37 ET
|
AngioDynamics
ALBANY, N.Y., Sept. 06, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Present at the 2016 Canaccord Genuity Growth Conference
August 08, 2016 14:30 ET
|
AngioDynamics
ALBANY, N.Y., Aug. 08, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...
AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders
August 01, 2016 16:30 ET
|
AngioDynamics
ALBANY, N.Y., Aug. 01, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...
AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
July 25, 2016 07:34 ET
|
AngioDynamics
ALBANY, N.Y., July 25, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
July 13, 2016 06:00 ET
|
AngioDynamics
Q4 Net sales of $93.4 million, up 3% year-over-yearQ4 GAAP loss per share of $1.21, inclusive of a one-time tax asset write down of $40.1 million; Non-GAAP adjusted EPS of $0.19, up 37%...
AngioDynamics to Report Fiscal 2016 Fourth Quarter and Full Year Financial Results
June 29, 2016 06:00 ET
|
AngioDynamics
ALBANY, N.Y., June 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...
AngioDynamics Reports Fiscal 2016 Third Quarter Results
April 07, 2016 16:01 ET
|
AngioDynamics
Net sales of $87.4 million, up 1% year-over-yearGAAP earnings per share of $0.02; Non-GAAP adjusted EPS of $0.15, up 25% year-over-yearOperating cash generation of $12.4 millionFY2016 financial...
AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer
April 04, 2016 08:00 ET
|
AngioDynamics
ALBANY, N.Y., April 04, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results
March 29, 2016 06:30 ET
|
AngioDynamics
ALBANY, N.Y., March 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral...
AngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients
March 10, 2016 06:30 ET
|
AngioDynamics
ALBANY, N.Y., March 10, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...